Astrocytic expression of HIV-1 viral protein R in the hippocampus causes chromatolysis, synaptic loss and memory impairment

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Torres, Lilith ^a   Noel Jr , Richard J ^a  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

astrocyte; HAND; learning; object recognition; rat model; synaptophysin

Indexed keywords

GREEN FLUORESCENT PROTEIN; NEUROTOXIN; SYNAPTOPHYSIN; VPR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CHROMATIN; CONTROLLED STUDY; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOREACTIVITY; LEARNING; LEARNING DISORDER; MEMORY DISORDER; NERVE CELL LESION; NEUROLOGIC DISEASE; NISSL STAINING; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SPATIAL MEMORY; SYNAPSE; TASK PERFORMANCE; VIRUS REPLICATION;

ANIMALS; ASTROCYTES; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; HUMANS; MALE; MAZE LEARNING; MEMORY DISORDERS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPACE PERCEPTION; SYNAPSES; SYNAPTOPHYSIN; TRANSDUCTION, GENETIC; TRANSFECTION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84899140299     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-53     Document Type: Article

References (80)

1. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio MA, Knysz B, Dietrich M, Phillips AN, Lundgren J. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003, 362:22-29. 10.1016/S0140-6736(03)13802-0, 12853195.
2. Panos G, Samonis G, Alexiou VG, Kavarnou GA, Charatsis G, Falagas ME. Mortality and morbidity of HIV infected patients receiving HAART: a cohort study. Curr HIV Res 2008, 6:257-260. 10.2174/157016208784324976, 18473789.
3. Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, Miller R, Tavolato B, Beckett AA, Scaravilli F. Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol 1997, 42:34-40. 10.1002/ana.410420108, 9225683.
4. An SF, Giometto B, Groves M, Miller RF, Beckett AA, Gray F, Tavolato B, Scaravilli F. Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 1997, 56:1262-1268. 10.1097/00005072-199711000-00011, 9370237.
5. McArthur J, Smith B. Neurologic complications and considerations in HIV-infected persons. Curr Infect Dis Rep 2013, 15:61-66. 10.1007/s11908-012-0312-2, 23307491.
6. Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010, 75:2087-2096. 10.1212/WNL.0b013e318200d727, 2995535, 21135382, CHARTER Group.
7. Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 2007, 45:174-182. 10.1097/QAI.0b013e318042e1ee, 17356465.
8. Heaton R, Franklin D, Ellis R, McCutchan J, Letendre S, LeBlanc S, Corkran S, Duarte N, Clifford D, Woods S, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group; HNRC Group HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011, 17:3-16. 10.1007/s13365-010-0006-1, 3032197, 21174240, CHARTER Group; HNRC Group.
9. Trillo-Pazos G, Diamanturos A, Rislove L, Menza T, Chao W, Belem P, Sadiq S, Morgello S, Sharer L, Volsky DJ. Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 2003, 13:144-154.
10. Tornatore C, Nath A, Amemiya K, Major EO. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 1991, 65:6094-6100. 250285, 1920627.
11. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988, 239:586-592. 10.1126/science.3277272, 3277272.
12. Messam CA, Major EO. Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue. J Neurovirol 2000, 6(Suppl 1):S90-S94.
13. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay CR, Sodroski J, Gabuzda D. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997, 385:645-649. 10.1038/385645a0, 9024664.
14. Ghorpade A, Nukuna A, Che M, Haggerty S, Persidsky Y, Carter E, Carhart L, Shafer L, Gendelman HE. Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia. J Virol 1998, 72:3340-3350. 109814, 9525661.
15. Thompson KA, Cherry CL, Bell JE, McLean CA. Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals. Am J Pathol 2011, 179:1623-1629. 10.1016/j.ajpath.2011.06.039, 3181362, 21871429.
16. Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, Gorry PR. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol 2009, 66:253-258. 10.1002/ana.21697, 19743454.
17. Tornatore C, Chandra R, Berger JR, Major EO. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994, 44:481-487. 10.1212/WNL.44.3_Part_1.481, 8145919.
18. Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Raininko R, Haapasalo H, Krohn K. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995, 9:1001-1008. 10.1097/00002030-199509000-00004, 8527071.
19. Brack-Werner R, Kleinschmidt A, Ludvigsen A, Mellert W, Neumann M, Herrmann R, Khim MC, Burny A, Muller-Lantzsch N, Stavrou D, et al. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS 1992, 6:273-285. 10.1097/00002030-199203000-00004, 1373627.
20. Vincendeau M, Kramer S, Hadian K, Rothenaigner I, Bell J, Hauck SM, Bickel C, Nagel D, Kremmer E, Werner T, Leib-Mösch C, Brack-Werner R. Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp). AIDS 2010, 24:2433-2442. 10.1097/QAD.0b013e32833e8758, 20827171.
21. Li W, Henderson LJ, Major EO, Al-Harthi L. IFN-gamma mediates enhancement of HIV replication in astrocytes by inducing an antagonist of the beta-catenin pathway (DKK1) in a STAT 3-dependent manner. J Immunol 2011, 186:6771-6778. 10.4049/jimmunol.1100099, 3167069, 21562161.
22. Tornatore C, Meyers K, Atwood W, Conant K, Major E. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J Virol 1994, 68:93-102. 236268, 8254781.
23. Halassa MM, Haydon PG. Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol 2010, 72:335-355. 10.1146/annurev-physiol-021909-135843, 3117429, 20148679.
24. Perea G, Navarrete M, Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 2009, 32:421-431. 10.1016/j.tins.2009.05.001, 19615761.
25. Navarrete M, Perea G, Fernandez de Sevilla D, Gomez-Gonzalo M, Nunez A, Martin ED, Araque A. Astrocytes mediate in vivo cholinergic-induced synaptic plasticity. PLoS Biol 2012, 10:e1001259. 10.1371/journal.pbio.1001259, 3279365, 22347811.
26. Deshpande M, Zheng J, Borgmann K, Persidsky R, Wu L, Schellpeper C, Ghorpade A. Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia. Neurotox Res 2005, 7:183-192. 10.1007/BF03036448, 15897153.
27. He J, Choe S, Walker R, Di MP, Morgan DO, Landau NR. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995, 69:6705-6711. 189580, 7474080.
28. Jones GJ, Barsby NL, Cohen EA, Holden J, Harris K, Dickie P, Jhamandas J, Power C. HIV-1 Vpr Causes Neuronal Apoptosis and In Vivo Neurodegeneration. J Neurosci 2007, 27:3703-3711. 10.1523/JNEUROSCI.5522-06.2007, 17409234.
29. Patel CA, Mukhtar M, Pomerantz RJ. Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J Virol 2000, 74:9717-9726. 10.1128/JVI.74.20.9717-9726.2000, 112404, 11000244.
30. Piller SC, Jans P, Gage PW, Jans DA. Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. Proc Natl Acad Sci USA 1998, 95:4595-4600. 10.1073/pnas.95.8.4595, 22535, 9539783.
31. Kitayama H, Miura Y, Ando Y, Hoshino S, Ishizaka Y, Koyanagi Y. Human immunodeficiency virus type 1 Vpr inhibits axonal outgrowth through induction of mitochondrial dysfunction. J Virol 2008, 82:2528-2542. 10.1128/JVI.02094-07, 2258941, 18094160.
32. Rom I, Deshmane SL, Mukerjee R, Khalili K, Amini S, Sawaya BE. HIV-1 Vpr deregulates calcium secretion in neural cells. Brain Res 2009, 1275:81-86. 2692350, 19328187.
33. Levy DN, Refaeli Y, MacGregor RR, Weiner DB. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1994, 91:10873-10877. 10.1073/pnas.91.23.10873, 45128, 7971975.
34. Pomerantz RJ. Effects of HIV-1 Vpr on neuroinvasion and neuropathogenesis. DNA Cell Biol 2004, 23:227-238. 10.1089/104454904773819815, 15142380.
35. Mukerjee R, Chang JR, Del Valle L, Bagashev A, Gayed MM, Lyde RB, Hawkins BJ, Brailoiu E, Cohen E, Power C, Azizi SA, Gelman BB, Sawaya BE. Deregulation of microRNAs by HIV-1 Vpr Protein Leads to the Development of Neurocognitive Disorders. J Biol Chem 2011, 286:34976-34985. 10.1074/jbc.M111.241547, 3186354, 21816823.
36. Gangwani MR, Noel RJ, Shah A, Rivera-Amill V, Kumar A. Human immunodeficiency virus type 1 viral protein R (Vpr) induces CCL5 expression in astrocytes via PI-3 K and MAPK signaling pathways. J Neuroinflammation 2013, 10:136. 10.1186/1742-2094-10-136, 3831867, 24225433.
37. Ferrucci A, Nonnemacher MR, Wigdahl B. Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival. J Neurovirol 2013, 19:239-253. 10.1007/s13365-013-0170-1, 23728617.
38. Amini S, Saunders M, Kelley K, Khalili K, Sawaya BE. Interplay between HIV-1 Vpr and Sp1 Modulates p21WAF1 Gene Expression in Human Astrocytes. J Biol Chem 2004, 279:46046-46056. 10.1074/jbc.M403792200, 15302882.
39. Chauhan A, Turchan J, Pocernich C, Bruce-Keller A, Roth S, Butterfield DA, Major EO, Nath A. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J Biol Chem 2003, 278:13512-13519. 10.1074/jbc.M209381200, 12551932.
40. Bruce-Keller AJ, Chauhan A, Dimayuga FO, Gee J, Keller JN, Nath A. Synaptic Transport of Human Immunodeficiency Virus-Tat Protein Causes Neurotoxicity and Gliosis in Rat Brain. J Neurosci 2003, 23:8417-8422.
41. Chompre G, Cruz E, Maldonado L, Rivera-Amill V, Porter JT, Noel RJ. Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory. Neurobiol Dis 2013, 49:128-136.
42. Frangakis MV, Kimelberg HK. Dissociation of neonatal rat brain by dispase for preparation of primary astrocyte cultures. Neurochem Res 1984, 9:1689-1698. 10.1007/BF00968079, 6397695.
43. Benice TS, Rizk A, Kohama S, Pfankuch T, Raber J. Sex-differences in age-related cognitive decline in C57BL/6 J mice associated with increased brain microtubule-associated protein 2 and synaptophysin immunoreactivity. Neuroscience 2006, 137:413-423. 10.1016/j.neuroscience.2005.08.029, 16330151.
44. Save E, Poucet B, Foreman N, Buhot MC. Object exploration and reactions to spatial and nonspatial changes in hooded rats following damage to parietal cortex or hippocampal formation. Behav Neurosci 1992, 106:447-456.
45. Poucet B. Spatial cognitive maps in animals: new hypotheses on their structure and neural mechanisms. Psychol Rev 1993, 100:163-182.
46. Moon HS, Yang JS. Role of HIV Vpr as a regulator of apoptosis and an effector on bystander cells. Mol Cells 2006, 21:7-20.
47. Borjabad A, Brooks AI, Volsky DJ. Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. J Neuroimmune Pharmacol 2010, 5:44-62. 10.1007/s11481-009-9167-1, 3107560, 19697136.
48. Snyder A, Ross MJ. Murine models of Vpr-mediated pathogenesis. Curr HIV Res 2009, 7:129-135. 10.2174/157016209787581526, 19275581.
49. Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 1995, 146:3-15. 1870771, 7856735.
50. Barr ML, Hamilton JD. A quantitative study of certain morphological changes in spinal motor neurons during axon reaction. J Comp Neurol 1948, 89:93-121. 10.1002/cne.900890203, 18889710.
51. Cammermeyer J. Peripheral Chromatolysis after Transection of Mouse Facial Nerve. Acta Neuropathol 1963, 3:213-230.
52. Popratiloff A, Kharazia VN, Weinberg RJ, Laonipon B, Rustioni A. Glutamate receptors in spinal motoneurons after sciatic nerve transection. Neuroscience 1996, 74:953-958. 10.1016/0306-4522(96)00300-4, 8895864.
53. Hanz S, Fainzilber M. Retrograde signaling in injured nerve-the axon reaction revisited. J Neurochem 2006, 99:13-19. 10.1111/j.1471-4159.2006.04089.x, 16899067.
54. Schmitt U, Tanimoto N, Seeliger M, Schaeffel F, Leube RE. Detection of behavioral alterations and learning deficits in mice lacking synaptophysin. Neuroscience 2009, 162:234-243. 10.1016/j.neuroscience.2009.04.046, 19393300.
55. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992, 32:321-329. 10.1002/ana.410320304, 1416802.
56. Liu Y, Liu H, Kim BO, Gattone VH, Li J, Nath A, Blum J, He JJ. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol 2004, 78:4120-4133. 10.1128/JVI.78.8.4120-4133.2004, 374297, 15047828.
57. Lopez-Herrera A, Liu Y, Rugeles MT, He JJ. HIV-1 interaction with human mannose receptor (hMR) induces production of matrix metalloproteinase 2 (MMP-2) through hMR-mediated intracellular signaling in astrocytes. Biochim Biophys Acta 2005, 1741:55-64. 10.1016/j.bbadis.2004.12.001, 15955449.
58. Fields RD, Stevens-Graham B. New insights into neuron-glia communication. Science 2002, 298:556-562. 10.1126/science.298.5593.556, 1226318, 12386325.
59. Barker AJ, Ullian EM. Astrocytes and synaptic plasticity. Neuroscientist 2010, 16:40-50. 10.1177/1073858409339215, 20236948.
60. Atluri VS, Kanthikeel SP, Reddy PV, Yndart A, Nair MP. Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND). PLoS One 2013, 8:e61399. 10.1371/journal.pone.0061399, 3631205, 23620748.
61. Ota Y, Zanetti AT, Hallock RM. The role of astrocytes in the regulation of synaptic plasticity and memory formation. Neural Plast 2013, 2013:185463. 3867861, 24369508.
62. Witcher MR, Kirov SA, Harris KM. Plasticity of perisynaptic astroglia during synaptogenesis in the mature rat hippocampus. Glia 2007, 55:13-23. 10.1002/glia.20415, 17001633.
63. Langford D, Marquie-Beck J, Almeida S, Lazzaretto D, Letendre S, Grant I, McCutchan JA, Masliah E, Ellis R. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. J Neurovirol 2006, 12:100-107. 10.1080/13550280600713932, 16798671.
64. Rudy JW, Sutherland RJ. The hippocampal formation is necessary for rats to learn and remember configural discriminations. Behav Brain Res 1989, 34:97-109. 10.1016/S0166-4328(89)80093-2, 2765175.
65. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003, 463:3-33. 10.1016/S0014-2999(03)01272-X, 12600700.
66. Clarke PG, Clarke S. Nineteenth century research on cell death. Exp Oncol 2012, 34:139-145.
67. Glucksmann A. Cell deaths in normal vertebrate ontogeny. Biol Rev 1951, 26:59-86. 10.1111/j.1469-185X.1951.tb00774.x, 24540363.
68. Cragg BG. What is the signal for chromatolysis?. Brain Res 1970, 23:1-21. 10.1016/0006-8993(70)90345-8, 4919474.
69. Lieberman AR. The axon reaction: a review of the principal features of perikaryal responses to axon injury. Int Rev Neurobiol 1971, 14:49-124.
70. Burnett MG, Zager EL. Pathophysiology of peripheral nerve injury: a brief review. Neurosurg Focus 2004, 16:E1.
71. Clarke JR, Cammarota M, Gruart A, Izquierdo I, Delgado-Garcia JM. Plastic modifications induced by object recognition memory processing. Proc Natl Acad Sci USA 2010, 107:2652-2657. 10.1073/pnas.0915059107, 2823877, 20133798.
72. Figueiredo CP, Clarke JR, Ledo JH, Ribeiro FC, Costa CV, Melo HM, Mota-Sales AP, Saraiva LM, Klein WL, Sebollela A, De Felice FG, Ferreira ST. Memantine rescues transient cognitive impairment caused by high-molecular-weight abeta oligomers but not the persistent impairment induced by low-molecular-weight oligomers. J Neurosci 2013, 33:9626-9634. 10.1523/JNEUROSCI.0482-13.2013, 23739959.
73. Kesner RP, Lee I, Gilbert P. A behavioral assessment of hippocampal function based on a subregional analysis. Rev Neurosci 2004, 15:333-351.
74. Li XG, Somogyi P, Ylinen A, Buzsaki G. The hippocampal CA3 network: an in vivo intracellular labeling study. J Comp Neurol 1994, 339:181-208. 10.1002/cne.903390204, 8300905.
75. Kesner RP. Behavioral functions of the CA3 subregion of the hippocampus. Learn Mem 2007, 14:771-781. 10.1101/lm.688207, 18007020.
76. Jahn R, Schiebler W, Ouimet C, Greengard P. A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci USA 1985, 82:4137-4141. 10.1073/pnas.82.12.4137, 397950, 3923488.
77. Wiedenmann B, Franke WW. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 1985, 41:1017-1028. 10.1016/S0092-8674(85)80082-9, 3924408.
78. Edelmann L, Hanson PI, Chapman ER, Jahn R. Synaptobrevin binding to synaptophysin: a potential mechanism for controlling the exocytotic fusion machine. EMBO J 1995, 14:224-231. 398074, 7835333.
79. Alder J, Xie ZP, Valtorta F, Greengard P, Poo M. Antibodies to synaptophysin interfere with transmitter secretion at neuromuscular synapses. Neuron 1992, 9:759-768. 10.1016/0896-6273(92)90038-F, 1356373.
80. Frick KM, Fernandez SM. Enrichment enhances spatial memory and increases synaptophysin levels in aged female mice. Neurobiol Aging 2003, 24:615-626. 10.1016/S0197-4580(02)00138-0, 12714119.